Oral malignancy and premalignancy

Overview of Oral Cancer

1. General Information

  • Oral cancer primarily includes squamous cell carcinoma (SCC), which constitutes over 90% of oral malignancies. SCC typically originates in the flat cells lining the oral cavity and can spread to adjacent structures.

  • Other types include:

    • Melanoma: a rare but aggressive form that arises from melanocytes in the oral mucosa.

    • Maxillary antral carcinoma: cancers located in the maxillary sinus, which can manifest with facial swelling or obstruction.

    • Salivary gland malignancies: tumors originating in salivary glands, with variations in type and aggression.

    • Intra-bony malignancies: cancers that arise within the jawbones, potentially complicating diagnosis due to their asymptomatic nature in early stages.

    • Sarcomas: a rare form of cancer originating from mesenchymal tissues in the oral cavity.

    • Lymphomas: can occur in the oral cavity, often affecting the lymphatic tissues.

    • Secondary carcinomas: cancers that spread to the oral area from other sites in the body, indicating advanced disease.

2. Incidence and Distribution

  • Oral SCC is among the top ten most common cancers globally, with over 300,000 new cases annually, reflecting significant public health concerns.

  • Geographical variations in incidence:

    • UK: ~13 per 100,000 males, 7 per 100,000 females

    • South Central Asia: >20 per 100,000

3. Cancer Statistics in the UK

  • Oral cancer is the 6th most common cancer in the UK, accounting for ~2% of new cancer diagnoses each year.

  • Over 12,000 new head and neck cancer cases are reported annually; the male-to-female ratio exceeds 2:1, indicative of higher risk behaviors among men.

  • The incidence of oral SCC has increased by 2.5% per year since 1989, raising concerns about prevention and awareness efforts.

  • Lifetime cancer risks for oral cavity cancers are notable: 1 in 84 for men and 1 in 160 for women, reflecting a considerable public health burden.

4. Prevention and Risk Factors

  • About 46% of oral cancers are preventable, emphasizing the need for targeted prevention strategies.

  • Over 60% of cases present at stages 3 or 4, indicating that many individuals are diagnosed at advanced stages.

  • Major risk factors include:

    • Smoking: tobacco use is the leading risk factor, with both cigarettes and smokeless tobacco significantly increasing risk.

    • Alcohol consumption: heavy drinking, especially combined with tobacco use, significantly elevates risk.

    • Human papillomavirus (HPV) infection: particularly HPV-16, which is increasingly recognized as a major cause of oropharyngeal cancers.

    • Immunosuppression: conditions like HIV/AIDS or the use of immunosuppressive drugs can heighten risk, allowing for opportunistic infections and malignancies.

    • Previous oral or pharyngeal cancers: individuals with a history of such tumors are at higher risk for recurrence or new tumors.

5. Clinical Presentation and Diagnosis

  • Oral SCC may present as crater-like ulcers, raised masses, or persistent leukoplakia (white patches that cannot be scraped off).

  • Common sites include:

    • Tongue: (45% of cases), where lesions may cause pain and affect speech.

    • Soft palate/trigone: (30%), which can obstruct breathing and swallowing.

    • Gingiva: (10%), leading to periodontal issues.

  • Diagnosis requires a biopsy to confirm the presence of malignant cells; staging follows TNM classification (Tumor, Node, Metastasis) to determine the extent of disease.

  • Early diagnosis is crucial and relies on thorough patient history, clinical examination, and awareness of risk factors for timely intervention.

6. Management Strategies

  • A multidisciplinary approach is essential for management including:

    • Surgery: To remove localized tumors, surgery is often the primary treatment. Surgical options may involve partial or total mandibulectomy or maxillectomy, depending on the extent of cancer. Immediate reconstruction techniques can support functional and aesthetic outcomes.

    • Radiation therapy: Used post-surgery for residual disease or as the primary treatment in non-operative candidates. Techniques like IMRT (Intensity-Modulated Radiation Therapy) help target cancer cells while sparing healthy tissue.

    • Chemoradiotherapy: Blending chemotherapy and radiation therapy is especially for advanced cases, targeting local and systemic disease. Chemotherapy regimens may depend on tumor type and staging and often have a supportive role in palliation.

    • Supportive Care:

      • Oral hygiene education is vital to prevent infections and complications during treatment. Regular dental care and accessible oral hygiene products (e.g., specialized mouthwashes) should be emphasized.

      • Mucositis management: due to chemotherapy/radiation side effects may include pain management (e.g., topical anesthetics), anti-inflammatory medications, and nutritional support (enteral feeding may be necessary in severe cases).

      • Nutritional support: Working with dietitians to create meal plans that meet increased nutritional needs, focusing on soft, high-protein foods that are easy to consume.

      • Psychosocial support: Counselors and support groups can aid patients in coping with the emotional challenges of diagnosis and treatment, providing resources for mental health care.

      • Long-term rehabilitation planning: Addressing functional impairments related to speech, swallowing (with speech therapists), and psychosocial support (including community reintegration programs).

  • Continuous monitoring and risk factor modification (such as tobacco cessation and reduced alcohol intake) are crucial for improved outcomes and overall oral health. Regular follow-ups and surveillance scans (e.g., periodic imaging) can facilitate early detection of recurrences or secondary cancers.